后他汀类药物时代对血脂管理的批判性评价

Jared Spitz MD , Jaideep Patel MD , Anandita Agarwala MD , Garima Sharma MD , Anurag Mehta MD , Pradeep Natarajan MD , Khurram Nasir MD, MPH , Pamela Morris MD , Roger S. Blumenthal MD , Michael D. Shapiro DO, MCR
{"title":"后他汀类药物时代对血脂管理的批判性评价","authors":"Jared Spitz MD ,&nbsp;Jaideep Patel MD ,&nbsp;Anandita Agarwala MD ,&nbsp;Garima Sharma MD ,&nbsp;Anurag Mehta MD ,&nbsp;Pradeep Natarajan MD ,&nbsp;Khurram Nasir MD, MPH ,&nbsp;Pamela Morris MD ,&nbsp;Roger S. Blumenthal MD ,&nbsp;Michael D. Shapiro DO, MCR","doi":"10.1016/j.jacadv.2025.101823","DOIUrl":null,"url":null,"abstract":"<div><div>The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is a large and growing number of nonstatin therapies available to manage elevated cholesterol levels. This expert panel seeks to review current international recommendations regarding lipid management. In addition, complex yet commonly encountered lipid-management cases are provided. Guidance on applying guideline-based recommendations as well as newer evidence to the evaluation and management of ASCVD-risk lipid management is then provided.</div></div>","PeriodicalId":73527,"journal":{"name":"JACC advances","volume":"4 6","pages":"Article 101823"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Critical Appraisal of Lipid Management in the Post-Statin Era\",\"authors\":\"Jared Spitz MD ,&nbsp;Jaideep Patel MD ,&nbsp;Anandita Agarwala MD ,&nbsp;Garima Sharma MD ,&nbsp;Anurag Mehta MD ,&nbsp;Pradeep Natarajan MD ,&nbsp;Khurram Nasir MD, MPH ,&nbsp;Pamela Morris MD ,&nbsp;Roger S. Blumenthal MD ,&nbsp;Michael D. Shapiro DO, MCR\",\"doi\":\"10.1016/j.jacadv.2025.101823\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is a large and growing number of nonstatin therapies available to manage elevated cholesterol levels. This expert panel seeks to review current international recommendations regarding lipid management. In addition, complex yet commonly encountered lipid-management cases are provided. Guidance on applying guideline-based recommendations as well as newer evidence to the evaluation and management of ASCVD-risk lipid management is then provided.</div></div>\",\"PeriodicalId\":73527,\"journal\":{\"name\":\"JACC advances\",\"volume\":\"4 6\",\"pages\":\"Article 101823\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772963X25002418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772963X25002418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

低密度脂蛋白-胆固醇在动脉粥样硬化性心血管疾病(ASCVD)发病机制中的作用已得到充分证实。脂质管理仍然是解决ASCVD的基石。除了他汀类药物治疗,还有大量的非他汀类药物治疗可用于控制胆固醇水平升高。该专家小组旨在审查目前有关脂质管理的国际建议。此外,提供了复杂但常见的脂质管理案例。然后提供了应用基于指南的建议的指南以及评估和管理ascvd风险脂质管理的新证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Critical Appraisal of Lipid Management in the Post-Statin Era
The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is a large and growing number of nonstatin therapies available to manage elevated cholesterol levels. This expert panel seeks to review current international recommendations regarding lipid management. In addition, complex yet commonly encountered lipid-management cases are provided. Guidance on applying guideline-based recommendations as well as newer evidence to the evaluation and management of ASCVD-risk lipid management is then provided.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC advances
JACC advances Cardiology and Cardiovascular Medicine
CiteScore
1.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信